Race for drug top supremacy heats up

Published: 2009-08-03 07:00:00

Updated: 2009-08-03 07:00:00

Industry watchers claim that the race for the top in the domestic pharmaceutical market is likely to continue to heat up this year among Korea’s top three pharmaceutical firms – Dong-A, Yuhan and Hanmi.

"Inspired by impressive earnings in the first half, the three leading drugmakers are expect...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK